Seminar iz veštačke inteligencije, 20. oktobar 2021.

Naredni sastanak Seminara biće održan onlajn u sredu, 20. oktobra 2021. od 19 do 20 časova.

Predavač: Mirjana Ivanović, redovni profesor, Prirodno-matematički fakultet, Univerzitet u Novom Sadu,


Naslov predavanja: ASCAPE - ARTIFICIAL INTELLIGENCE SUPPORTING CANCER PATIENTS ACROSS EUROPE (H2020 PROJECT)

Apstrakt:
The ASCAPE project lasts 36 months and includes a competitive consortium of 15 partners from 7 countries (now we are at the end of the second year).

The main objective of ASCAPE is to take advantage of the recent ICT innovations in Big Data, Artificial Intelligence and Machine Learning to support cancer patients’ quality of life and health status. To achieve its objective, an open AI infrastructure is foreseen to be created that will enable health stakeholders (hospitals, research institutions, companies, etc.) to deploy and execute its AI algorithms locally on their private data. Any new knowledge produced by this process will be sent back to the open AI infrastructure and it can be used by other health stakeholders.
Whole process is based on Federated learning approach and communication between hospital Edge nodes and central Cloud infrastructure. The services to be designed, piloted and deployed inside this project will include intelligent interventions for patients’ support, improved patient and family counselling and guidance, early diagnosis and forecasts of ill-health, identification of disease trajectories and relapse, improved health literacy etc.

At the moment, ASCAPE is focused on intensive training/validating of the AI/ML models in two types of cancer, breast and prostate. In this presentation current state of the development of AI infrastructure will be reported.

Registraciona forma za učesće na Seminaru je dostupna na:
https://miteam.mi.sanu.ac.rs/asset/CW5nJWDSEZDj7p32p

Prenos seminara je dostupan i registrovanim i neregistrovanim korisnicima na sledećem linku:
https://miteam.mi.sanu.ac.rs/asset/4LNW8WtML7rLKojoz


 Ostavite vaš komentar 

Komentari(0)

Nažalost nije moguće ostaviti komentar.